Peptomyc is located in Barcelona, Spain on Carrer de Natzaret, 115,. Peptomyc is rated 4 out of 5 in the category biotechnology company in Spain. Peptomyc is a company focused on the development of a new generation of cell penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research on Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.
Address
Carrer de Natzaret, 115,
Company size
11-50 employees
Headquarters
Barcelona, Catalonia